FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
This Quarter Return
-21.62%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$111M
AUM Growth
+$111M
(+2.1%)
Cap. Flow
+$23.5M
Cap. Flow
% of AUM
21.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
MAZE
Maze Therapeutics, Inc. Common Stock
MAZE
|
$23.3M |
| 2 |
Lyell Immunopharma
LYEL
|
$4.13M |
| 3 |
Pharvaris
PHVS
|
$199K |
Top Sells
| 1 |
Kura Oncology
KURA
|
$4.06M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pharvaris
PHVS
$1.39B
| $69.2M | 62.35% | 4,410,581 +12,700 | +0.3% | +$199K |
|
|
MAZE
2
Maze Therapeutics, Inc. Common Stock
MAZE
$635M
| $23.3M | 20.93% | +2,111,919 | New | +$23.3M |
|
|
3
Lyell Immunopharma
LYEL
$213M
| $8.61M | 7.75% | 16,007,999 +7,682,999 | +92% | +$4.13M |
|
|
4
Kura Oncology
KURA
$686M
| $7.34M | 6.61% | 1,111,882 -615,000 | -36% | -$4.06M |
|
5
Relay Therapeutics
RLAY
$619M
| $2.62M | 2.36% | 1,000,000 | – | – |
|